A National, Multi-Center, Open-Label Study of Velcade in Combination With Melphalan and Prednisone (V-MP) in Older Untreated Multiple Myeloma Patients.
Phase of Trial: Phase I/II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Bortezomib; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2006 New trial record.